Bcel stock forecast.

At the time of writing, Atreca Inc [BCEL] stock is trading at $0.21, saw in change for the day. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The BCEL shares have gain 4.79% over the last week, with a monthly amount drifted -4.55%, and

Bcel stock forecast. Things To Know About Bcel stock forecast.

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Atreca Inc (BCEL) Stock Price & News - Google Finance Home BCEL • NASDAQ Atreca Inc Follow Share $0.21 After Hours: $0.22 (2.90%) +0.0062 Closed: Nov 24, 3:00:17 PM GMT-5 · USD · NASDAQ ·...Atreca (BCEL) Insider Trading Activity 2023. All the trading advice you’ve ever received boils down to this (Ad) How major US stock indexes fared Friday, 12/1/2023. US targets oil and natural gas industry's role in global warming with new rule on methane emissions. S&P 500 4,594.63. DOW 36,245.50.Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business. Zacks News for BCEL Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37% 08/14/23-9:51AM EST Zacks Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now 04/06/23-8:55AM EST ...

May 10, 2023 · On May 10, 2023, Atreca (NASDAQ:BCEL) announced its financial results for the first quarter of the year. The company reported Atreca Reports Q1 2023 Financial Results with Exceeding Analyst Estimates - Best Stocks 4/13 ratings generated profit. 31%. Average Return. -37.24%. reiterated a buy rating 10 months ago. Copying Do Kim 's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -37.24% per trade. 2 Years. dummy dummy.

9.19M. AMZN. 146.74. +0.02%. 21.10M. New. View today's Atreca Inc stock price and latest BCEL news and analysis. Create real-time notifications to follow any changes in the live stock price.Atreca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Find the latest ProPetro Holding Corp. (PUMP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cheniere Energy share forecasts, stock quote and buy / sell signals below. According to present data Cheniere Energy's LNG shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).October 13, 2023. At the time of writing, Atreca Inc [BCEL] stock is trading at $0.38, up 61.06%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BCEL shares have gain 66.93% over the last week, with a monthly amount glided 11.79%, and seem to be holding up well over a long-time horizon.

Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...

Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ...

Nov 16, 2023 · Analysts have been projecting $1.00 as a low price target for the stock while placing it at a high target of $9.00. It follows that stock’s current price would drop -4400.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -400.0% for stock’s current value. Atreca Inc (BCEL) estimates and forecasts Nov 30, 2023 · Read Full Company Summary for BCEL here. View Atreca, Inc BCEL investment & stock information. Get the latest Atreca, Inc BCEL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find real-time NU - Nu Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Cenovus Energy Inc () Stock Market info Recommendations: Buy or sell Cenovus Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cenovus Energy share forecasts, stock quote and buy / sell signals below.According to present data Cenovus Energy's CVE shares and potentially its market environment have …Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...

Nov 6, 2023 · Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum. Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25. Earnings Summary. For their last quarter, Atreca (BCEL) reported earnings of -$0.49 per share, beating the Zacks Consensus Estimate of $-0.56 per share. This reflects a positive earnings surprise ...Performance Outlook. Short Term. 2W - 6W. Mid Term. 6W - 9M. Long Term. 9M+ Previous Close: 0.2197 ... Stock Falls 37%. Atreca (BCEL) suspends the development of only pipeline candidate, ATRC-101 ...Atreca, Inc. (BCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BCEL Stock Predictions, Articles, and Atreca Inc Cl A News From InvestorPlace From the Web 3 Penny Stocks to Catapult You Into the Millionaires’ Club By Omor Ibne Ehsan Jul 13, 2023 ...February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.

Stock Price Forecast. The 31 analysts offering 12-month price forecasts for Li Auto Inc have a median target of 51.77, with a high estimate of 81.63 and a low estimate of 35.76. The median ...Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Keurig Dr Pepper Inc have a median target of 37.00, with a high estimate of 42.00 and a low estimate of 27.00. The ...Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | NasdaqAug 14, 2023 · BCEL Earnings Date and Information. Atreca last posted its quarterly earnings data on May 10th, 2023. The reported ($0.54) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.02. Atreca has generated ($2.18) earnings per share over the last year ( ($2.18) diluted earnings per share). The average Adma Biologics stock price prediction forecasts a potential upside of 43.11% from the current ADMA share price of $3.96. What is ADMA's forecast return on equity (ROE) for 2023-2026? (NASDAQ: ADMA) forecast ROE is N/A, which is considered weak.Atreca, Inc.’s BCEL shares plunged about 37% on Aug 11, 2023, after the company reported structural changes in its business in the second-quarter earnings release, which failed to meet investors ...Zacks Equity Research. April 6, 2023 at 9:55 AM · 3 min read. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer chart pattern was ...Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for Atreca stock is $3.38, which predicts an increase of 1,472.09%. The lowest target is $1.00 and the highest is $10. On average, analysts rate Atreca stock as a hold.Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Kroger Co have a median target of 51.75, with a high estimate of 65.00 and a low estimate of 37.00. The median estimate ...This reflects a positive earnings surprise of 12.50%. Look out for BCEL's next earnings release expected on November 09, 2023. For the next earning release, we expect the company to report ...

BCEL Earnings Date and Information. Atreca last posted its quarterly earnings data on May 10th, 2023. The reported ($0.54) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.02. Atreca has generated ($2.18) earnings per share over the last year ( ($2.18) diluted earnings per share).

Atreca Inc. Cl A analyst ratings, historical stock prices, earnings estimates & actuals. BCEL updated stock price target summary.

Find the latest Patterson-UTI Energy, Inc. (PTEN) stock quote, history, news and other vital information to help you with your stock trading and investing.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Coterra Energy share forecasts, stock quote and buy / sell signals below. According to present data Coterra Energy's CTRA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Find real-time KR - Kroger Co stock quotes, company profile, news and forecasts from CNN Business.The shares of micro-cap biotech, Atreca (BCEL +46.1%) have added more than a third in morning hours on Friday after the company updated early-stage data for its lead cancer candidate ATRC-101 with ...Find the latest Atreca, Inc. (BCEL) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.The Cymabay Therapeutics Inc stock price gained 6.70% on the last trading day (Friday, 24th Nov 2023), rising from $17.90 to $19.10. During the last trading day the stock fluctuated 6.58% from a day low at $17.92 to a day high of $19.10. The price has risen in 8 of the last 10 days and is up by 28.53% over the past 2 weeks.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The ...11.85 %. The 3 Wall Street analysts offering Atreca stock forecast in the last 6 months have average price target of $9.0 with a high forecast of $25.0 and a low forecast of $1.0. The average Atreca stock forecast represents a 3729.79% increase from the last price of $0.234999999403953. From AI system, total return is 2366.52% from 4098 forecasts. Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.

3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price.ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.11.30% of Atreca stock is owned by insiders. Which Atreca insiders have been selling company stock? The following insiders have sold BCEL shares in the last 24 months: Bros. Advisors Lp Baker ($109,895.60), John A Orwin ($37,216.24), Phillips Courtney ($15,321.16), and Tito Serafini ($199,122.53).Dec 1, 2023 · 3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price. Instagram:https://instagram. first mining gold stock pricestock bbaimetal company stocksunited capital goldman sachs Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of approximately 1,600%. This prediction is based on a high estimate of $35.00 and a low estimate of $11.00. first republick bank stockcubesma Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Allakos Inc have a median target of 9.50, with a high estimate of 22.00 and a low estimate of 1.50. The median estimate ...Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ... man u shares price Dec 1, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for BCEL. The average twelve-month price prediction for Atreca is $10.75 with a high price target of $25.00 and a low price target of $4.00. Learn more on BCEL's analyst rating history. Learn more about Atreca Inc's (BCEL) stock grades for Momentum, Growth and Estimate Revisions and determine whether this Biotechnology & Medical Research stock meets your investment needs. ... The Biotechnology and Medical Research sub-industry has a positive outlook, a historically defensive sub-industry. Drug sales are …